Research published by THE SAGE GROUP examines PAD disparities in African Americans and the contributing factors, as well as quantifies PAD prevalence in AA.
“While it is well known that African Americans have a higher prevalence of PAD, prior to this publication, there were no estimates of the number of AA with PAD,” stated Mary L. Yost, President of THE SAGE GROUP.
“African Americans represent 12% of the U.S. population ages 45 and older. However, they account for 24% of those with PAD. Furthermore, AA account for 30% of those with critical limb ischemia (CLI), the most severe and deadly form of PAD,” continued Yost.
“Not only are there racial differences in PAD prevalence and severity, but there are also significant differences in treatments and outcomes. Compared to Whites, AA are more likely to be hospitalized and have a greater risk of major amputation. Disease severity does not explain this disparity,” Ms. Yost stated.
“Black race is an independent risk factor for major amputation, increasing the risk by 1X-4X. Black women are at the highest risk of amputation with almost 8X the risk versus White women,” declared Yost.
“Numerous factors contribute to the higher prevalence of PAD/CLI, greater disease severity and poorer treatment outcomes in AA. These include differences in risk factors and comorbidities, higher prevalence of risk factors, greater impact of multiple risk factors, lower socioeconomic status, geography, female gender, lower disease awareness, discrimination and genetics,” Yost explained.
“Several relatively ignored factors contribute significantly to racial disparities including female gender, microvascular disease, chronic kidney disease, socioeconomic status and genetic variants. With the exception of socioeconomic status, none of these have previously been the focus of much discussion,” continued Yost.
About the Report: Peripheral Artery Disease in African Americans: Prevalence, Review of Disease Disparities and Causes of These Disparities.
This analysis estimates the U.S. prevalence of PAD in African Americans in the 2020-2040 period by disease severity. The report provides a comprehensive analysis of disease disparities and the causes of these disparities.
THE SAGE GROUP, a research and consulting company, specializes in PAD, CLI and venous disease.
Additional information: www.thesagegroup.us.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220519005858/en/
Contacts
THE SAGE GROUP
Mary Yost, (404) 520-6652
yost@thesagegroup.us